GT Biopharma, Inc. (GTBP) vs Quoin Pharmaceuticals, Ltd. Sponsored ADR (QNRX)

GT Biopharma, Inc. and Quoin Pharmaceuticals, Ltd. Sponsored ADR are both Biotechnology companies. GT Biopharma, Inc. and Quoin Pharmaceuticals, Ltd. Sponsored ADR are of similar size ($12.8M and $12.3M). Across the 9 metrics below, GT Biopharma, Inc. leads on 6 and Quoin Pharmaceuticals, Ltd. Sponsored ADR on 3.

Valuation

Metric GTBP QNRX Biotechnology median
P/E n/m n/m 7.88
P/S 178.31 n/m 11.47
P/B 3.00 4.63 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 96.13 n/m 10.73
Earnings yield (2,140.78%) (391.60%) (28.84%)
Free cash flow yield (133.29%) (15.72%) (23.03%)

Profitability

Metric GTBP QNRX Biotechnology median
Gross margin 41.67% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 102.03% (575.73%) (57.72%)
Return on assets (176.27%) (178.77%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GTBP QNRX Biotechnology median
Revenue growth (TTM) (76.19%) — 5.64%
EPS growth (last fiscal year) 3.75% 77.84% —
Revenue growth, 5-year CAGR 19.67% — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GTBP QNRX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.61 1.76 4.73
Net debt to EBITDA 0.56 1.16 0.96

Dividend

Metric GTBP QNRX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric GTBP QNRX Biotechnology median
Market cap 12.32m 12.82m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack